Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumorsAnastasios Stathis, C. Sessa, Roger von Moos et al.|Investigational New Drugs|2017Cited by 32
557P Binimetinib, pemetrexed (Pem) and cisplatin (Cis), followed by maintenance of Binimetinib and Pem in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations: The phase Ib SAKK 19/16 trialPatrizia Froesch, Martin Früh, Sacha I. Rothschild et al.|Annals of Oncology|2020Cited by 1